Bladder Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Imaging tests (such as ultrasound, CT, or MRI) have found a growth in your bladder that may be bladder cancer
- Your bladder can be fully filled with fluid for the scan, and you have no known allergic reactions to ultrasound contrast agents (a special dye used during scans)
- You have not previously had surgery, radiotherapy, or chemotherapy for this condition
- You are a suitable candidate for surgery and have at least one of the following: symptoms that suggest possible bladder cancer (such as visible blood in your urine); a confirmed diagnosis of new or returned bladder cancer from a camera test of the bladder (cystoscopy) with a tissue sample; or urine tests that suggest the presence of cancer cells
Who may not be able to join:
- People who are not well enough to have surgery
- People who are allergic to ultrasound contrast agents (the special dye used in certain scans) and therefore cannot have this type of scan
- People whose pre-surgery ultrasound contrast scan could not be completed successfully, or who are unable to follow the study procedures
- People whose tissue sample results after surgery do not confirm bladder cancer
- People who have already received chemotherapy or radiation therapy
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Qiyun Ou, Dr., Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phone: (86)020-34071020
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Detection of Muscle Invasion in Bladder Cancer
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.